American Headache Society Annual Scientific Meeting (AHS)
The American Headache Society (AHS) Annual Scientific Meeting is designed for physicians, psychologists, scientists, researchers, physician assistants, nurse practitioners, and other health professionals involved in the care of patients with head, neck, and orofacial pain. It aims to disseminate the most up-to-date research and scientific advances underlying the practice of headache medicine.
Assessing Long-Term Benefit of Eptinezumab for Chronic Migraine: Amaal Starling, MD, FAHS, FAAN
Published: July 1st 2024 | Updated: July 1st 2024The associate professor of neurology at Mayo Clinic College of Medicine discussed findings from a post-hoc analysis of the phase 3 PREVAIL study presented at AHS 2024 assessing eptinezumab in patients with chronic migraine. [WATCH TIME: 4 minutes]
A Time to Recognize and Enhance Understanding of Migraine Disorders: Jessica Ailani, MD
June 21st 2024The director of the MedStar Georgetown Headache Center talked about recognizing the struggles of patients with migraine disorders and the importance of bringing awareness of available treatments to this patient population. [WATCH TIME: 5 minutes]
Eptinezumab’s Real-World Impact as Chronic Migraine Treatment: Amaal Starling, MD, FAHS, FAAN
November 28th 2023The associate professor in the department of neurology at Mayo Clinic College of Medicine talked about findings from a real-world study assessing eptinezumab among patients with chronic migraine which was presented at the AHS Scottsdale Headache Symposium 2023. [WATCH TIME: 4 minutes]
Advancements and Updates to the Treatment Algorithm of Migraine: Emad Estemalik, MD
November 19th 2023The director of the headache section at Cleveland Clinic’s Neurological Institute gave an administrative perspective on the changes to how patients with migraine are cared for, led by significant developments in recent years. [WATCH TIME: 4 minutes]
Excitement Behind the 2023 American Headache Society Symposium: Emad Estemalik, MD
November 16th 2023The director of the headache section at Cleveland Clinic’s Neurological Institute provided commentary on the advances in the field of migraine and reasons to be excited about the 2023 AHS symposium in Scottsdale, Arizona. [WATCH TIME: 3 minutes]
Reframing the Communication of Lifestyle Changes for Migraine Management: Elizabeth Seng, PhD
September 8th 2023The associate professor at Yeshiva University and Albert Einstein College of Medicine explored the challenge of discussing lifestyle changes for patients with migraine, noting that lifestyle modifications can be a valuable addition to migraine treatment. [WATCH TIME: 3 minutes]
Debunking Myths of Migraine’s Role in Dementia: Olivia Begasse de Dhaem, MD, FAHS
September 6th 2023The headache specialist at Hartford Healthcare Headache Center emphasized the importance of avoiding unnecessary fear surrounding the potential link between migraine and dementia, as current evidence does not strongly support it being a significant risk factor. [WATCH TIME: 2 minutes]
Retinal Vasculature Changes in Migraine With Aura: Katherine Podraza, MD, PhD
August 18th 2023The headache specialist at the Hartford Healthcare Headache Center discussed findings from a study that revealed altered retinal vasculature in individuals with migraine with aura, indicating potential retinal biomarkers for disease progression. [WATCH TIME: 4 minutes]
Empowering Behavior Change in Migraine Through Motivational Interviewing: Elizabeth Seng, PhD
August 16th 2023The associate professor at Yeshiva University and Albert Einstein College of Medicine discussed the significance of motivational interviewing as a means for providers to engage with their patients and the harmful impact of societal stereotypes on individuals with migraine. [WATCH TIME: 5 minutes]
Proper Ways to Engage Underserved Populations in Pain Medicine: Burel Goodin, PhD
August 10th 2023The professor of anesthesiology at Washington University in St. Louis provided perspective on the respect and approach that comes with conducting research in underserved or impoverished communities. [WATCH TIME: 4 minutes]
Identifying Effective Big Data Techniques to Address Heterogeneity in Migraine: Ali Ezzati, MD
July 13th 2023The director of the Neuroinformatics Program at the University of California, Irvine, discussed complexities with different machine learning algorithms in migraine research, including findings from the AMPP study. [WATCH TIME: 5 minutes]
Efforts Needed to Reach Underserved Communities, Advance Pain Medicine Research: Burel Goodin, PhD
July 12th 2023The professor of anesthesiology at Washington University in St. Louis discussed the reasons behind his presentation at the 2023 AHS Annual Meeting on engaging underserved populations in pain medicine research. [WATCH TIME: 3 minutes]
Burel Goodin, PhD, on Building Trust in Underserved Communities to Improve Clinical Trial Outcomes
July 5th 2023The professor of anesthesiology at Washington University in St. Louis discussed the importance of effectively communicating and reciprocating with underserved communities that are of research interest.
AHS Annual Scientific Meeting 2023: Top Expert Interviews
June 30th 2023A group of experts in the care of patients with neurological conditions—Amynah Pradhan, PhD; Katherine Podraza, MD, PhD; Elizabeth K. Seng, PhD; Olivia Begasse de Dhaem, MD, FAHS; Sait Ashina, MD, FAHS—shared their perspectives on hot topics of treatment and management in headache/migraine from the 2023 American Headache Society Annual Scientific Meeting.
Episode 92: Highlights From the 2023 CMSC, SLEEP, AHS, and ATMRD Annual Meetings
June 30th 2023Mind Moments®, a podcast from NeurologyLive®, brings you exclusive interviews with Amit Bar-Or, MD; Gavin Giovannoni, MBBCh, PhD; Dayna Johnson, PhD, MPH, MSW, MS; John Winkelman, MD, PhD; Laxman Bahroo, DO; Ling Wan-Albert, OTD, OTR/L; Sara Pavitt, MD; and Ali Ezzati, MD. [LISTEN TIME: 28 minutes]
Future Research on Cannabis Use to Treat Migraine: Nathaniel Schuster, MD
June 29th 2023The pain management specialist and headache neurologist at the University of California San Diego Center for Pain Medicine discussed the different forms of cannabis and the need to conduct larger, multicenter studies to better understand its effects in migraine. [WATCH TIME: 3 minutes]
Tension-Type Headache, An Understudied and Undertreated Condition: Sait Ashina, MD, FAHS
June 25th 2023The assistant professor of neurology at Harvard Medical School talked about the prevalence of tension-type headache and how recent advances shed light on its pathophysiological mechanisms, leading to potential new treatments for the condition. [WATCH TIME: 5 minutes]
Gut-Brain Interaction, the Overlapping Connection Between Cyclic Vomiting and Migraine
June 23rd 2023B U. K. Li, MD, emeritus professor of pediatrics and gastroenterology at the Medical College of Wisconsin, highlights the significant overlap between cyclic vomiting syndrome, abdominal migraine, and migraine headaches.
Galcanezumab Shows Greatest Reduction in Disease Burden Following Switching
June 21st 2023Following the initiation or switch to a new migraine preventive medication, patients taking galcanezumab showed numerically greater 3-month improvements for most measures of health-related quality of life and disability.
Management and Impact of Migraine During Pregnancy: Rashmi Halker Singh, MD
June 21st 2023The associate professor of neurology at Mayo Clinic discussed the developing field of migraine management during pregnancy and the importance of raising awareness of treatment options during the gestation period. [WATCH TIME: 4 minutes]
NeuroVoices: Sara Pavitt, MD, on the Need to Educate the Clinical Community on Pediatric Headache
June 21st 2023At the 2023 AHS Annual Meeting, the chief of headache at UT Austin Dell Children’s Hospital discussed her presentation on a new educational intervention to improve knowledge of pediatric headache.
